Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Cardiac Resynchronization Therapy in Infant with Dilated Cardiomyopathy during Extracorporeal Membrane Oxygenator

  • Bang, Ji Hyun (Divisions of Pediatric Cardiac Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Oh, You Na (Divisions of Pediatric Cardiac Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Ko, Jae-Kon (Divisions of Pediatric Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kang, So Yeon (Divisions of Pediatric Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Baek, Jae Suk (Divisions of Pediatric Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Chun Soo (Divisions of Pediatric Cardiac Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2014.07.22
  • Accepted : 2014.10.02
  • Published : 2015.02.05
Download PDF
⟨ Previous Next ⟩

Abstract

Although heart transplantation is a final therapeutic option in pediatric patients with dilated cardiomyopathy (DCMP), the shortage of pediatric heart donors is a major obstacle. In adults with DCMP characterized by cardiac dyssynchrony, cardiac resynchronization therapy (CRT) is known to be an effective treatment option. However, there is a lack of evidence on the effectiveness of CRT in infants with DCMP. Several studies have reported improvement in hemodynamics and cardiac performance following CRT in infants with DCMP. Here, we report CRT in an infant with DCMP during extracorporeal membrane oxygenation with 5 months of follow-up.

Keywords

References

  1. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53. https://doi.org/10.1056/NEJMoa013168
  2. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344: 873-80. https://doi.org/10.1056/NEJM200103223441202
  3. Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society [corrected]. Circulation 2012;126:1784-800. https://doi.org/10.1161/CIR.0b013e3182618569
  4. Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol 2005; 46:2277-83. https://doi.org/10.1016/j.jacc.2005.05.096
  5. Cecchin F, Frangini PA, Brown DW, et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol 2009;20:58-65. https://doi.org/10.1111/j.1540-8167.2008.01274.x
  6. Cannesson M, Gostoli B, Rosamel P, et al. Successful cardiac resynchronization therapy after cardiac surgery. Anesth Analg 2007;104:71-4. https://doi.org/10.1213/01.ane.0000246795.57769.23
  7. Pecha S, Yildirim Y, Reichenspurner H, Deuse T. Successful extracorporeal membrane oxygenation weaning after cardiac resynchronization therapy device implantation in a patient with end-stage heart failure. Interact Cardiovasc Thorac Surg 2012;15:922-3. https://doi.org/10.1093/icvts/ivs338

Cited by

  1. Cardiac Resynchronization Therapy Device Implantation in a Patient with Cardiogenic Shock under Percutaneous Mechanical Circulatory Support vol.47, pp.1, 2017, https://doi.org/10.4070/kcj.2016.0176